Search results for "Pulmonary disease"
New warnings for gabapentinoids; other drugs approved
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2020/02/new-warnings-for-gabapentinoids-other-drugs-approved.htm
1 Feb 2020
Shorter regimens can boost adherence in latent TB infection
Treatment is essential to reducing disease incidence.
https://immattersacp.org/archives/2020/01/shorter-regimens-can-boost-adherence-in-latent-tb-infection.htm
1 Jan 2020
Vitamin E acetate linked to vaping-associated lung injury
The total number of reported vaping-associated lung injury cases mounted to 2,172, the CDC found vitamin E acetate in biologic samples for the first time, and authors of an observational study of vaping-related illness emphasized that patients may present with flu-like and abdominal symptoms.
https://immattersacp.org/weekly/archives/2019/11/19/1.htm
19 Nov 2019
New thinking about Alzheimer's diagnosis
New technology and biomarkers have contributed to the detection of Alzheimer's disease, but clinicians are skeptical about the value of a diagnosis without the ability to treat the condition.
https://immattersacp.org/archives/2019/11/new-thinking-about-alzheimers-diagnosis.htm
1 Nov 2019
Metoprolol not effective for reducing time to COPD exacerbation
A randomized placebo-controlled trial, which was stopped early due to safety and futility concerns, found no significant between-group difference in median time to first exacerbation of chronic obstructive pulmonary disease (COPD).
https://immattersacp.org/weekly/archives/2019/10/29/4.htm
29 Oct 2019
New model found to help predict 20-year risk of COPD
Prediction of future lung function could let clinicians identify those at high risk for chronic obstructive pulmonary disease (COPD), but the trajectory of lung function decline varies greatly among individuals, the authors noted.
https://immattersacp.org/weekly/archives/2019/10/01/4.htm
1 Oct 2019
CDC asks physicians to report cases of vaping-related respiratory illness
Three hundred eighty possible cases of pulmonary disease related to e-cigarette use in 36 states and one U.S. territory had been reported as of Sept. 12, and six patients have died.
https://immattersacp.org/weekly/archives/2019/09/17/1.htm
17 Sep 2019
Testing CRP level safely reduced antibiotic use in patients with COPD exacerbation
In patients with chronic obstructive pulmonary disease (COPD) exacerbations, point-of-care testing of C-reactive protein (CRP) level decreased antibiotic use without affecting clinical outcomes, a randomized controlled trial found.
https://immattersacp.org/weekly/archives/2019/07/16/1.htm
16 Jul 2019
New reasons to worry about e-cigs
Experiments have shown negative biological effects from the flavor chemicals in e-cigarettes.
https://immattersacp.org/archives/2019/07/new-reasons-to-worry-about-e-cigs.htm
1 Jul 2019
Bringing medicine to the streets
A newly formed street medicine fellowship is allowing academic centers and cities to bring care to homeless patients instead of waiting for them to present to a hospital or shelter.
https://immattersacp.org/archives/2019/07/bringing-medicine-to-the-streets.htm
1 Jul 2019